Loading organizations...
YuanMing Prudence Fund, operating as HONGKONG YUANMING FUND MANAGEMENT CO., LIMITED, specializes in offshore and cross-border asset management. The firm leverages an experienced investment and research team to provide tailored investment solutions. Its approach emphasizes a disciplined investment process coupled with a robust risk management framework, aiming to identify profitable opportunities and generate consistent outperformance for its clients.
The company was incorporated in Hong Kong on November 9, 2020. It was established with the insight that the deepening relationship between global and Chinese markets, alongside increasing two-way capital flows, created a significant need for specialized expertise in cross-border financial services. The senior management team comprises professionals with extensive experience from international financial institutions.
YuanMing Prudence Fund serves investors seeking exposure to sophisticated cross-border asset management strategies. The firm is committed to delivering superior long-term returns while maintaining stringent risk controls, aligning its services with the unique return and risk objectives of each client. Its vision is to be a trusted partner in navigating the complexities of the global and Chinese capital markets.
YuanMing Prudence Fund has 1 tracked investment across 1 company. The latest tracked deal is $98.0M Series D in CANbridge Pharmaceuticals in February 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 18, 2020 | CANbridge Pharmaceuticals | $98.0M Series D | Lefei SUN, WuXi AppTec | Hudson BAY Capital, Derek Dirocco, Tigermed |